Does HPV type affect outcome in oropharyngeal cancer?

Journal of Otolaryngology - Head and Neck Surgery

Volumn 42, Issue FEB, 2013, Pages

  Nichols, Anthony C ^a,b,c   Dhaliwal, Sandeep S ^a   Palma, David A ^a,b,c   Basmaji, John ^a   Chapeskie, Corina ^a   Dowthwaite, Samuel ^a   Franklin, Jason H ^a,b   Fung, Kevin ^a,b   Kwan, Keith ^a   Wehrli, Brett ^a   Howlett, Chris ^a   Siddiqui, Iram ^a   Salvadori, Marina I ^a   Winquist, Eric ^a,b   Ernst, Scott ^a,b   Kuruvilla, Sara ^a,b   Read, Nancy ^a,b   Venkatesan, Varagur ^a,b   Todorovic, Biljana ^a,b   Hammond, J Alex ^a,b   Koropatnick, James ^a,b,c   Mymryk, Joe S ^a,b,c   Yoo, John ^a,b   Barrett, John W ^a,b,c   more..

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

^b LONDON REGIONAL CANCER PROGRAM   (Canada)

^c LAWSON HEALTH RESEARCH INSTITUTE   (Canada)

Author keywords

Epidemiology; Human papillomavirus; Oropharyngeal cancer

Indexed keywords

PROTEIN P16;

AGE; ALCOHOL CONSUMPTION; ARTICLE; CANCER CLASSIFICATION; CANCER LOCALIZATION; CANCER SURVIVAL; CONTROLLED STUDY; DISEASE FREE SURVIVAL; DISEASE SEVERITY; FEMALE; GENDER; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; METASTASIS; ORAL BIOPSY; OROPHARYNGEAL SQUAMOUS CELL CANCER; OROPHARYNX CANCER; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; RETROSPECTIVE STUDY; SMOKING; UTERINE CERVIX METASTASIS; AGED; ALPHAPAPILLOMAVIRUS; CANADA; CLASSIFICATION; EPIDEMIOLOGY; HEAD AND NECK TUMOR; MIDDLE AGED; MORTALITY; OROPHARYNX TUMOR; POLYMERASE CHAIN REACTION; PROGNOSIS; SQUAMOUS CELL CARCINOMA; VIROLOGY;

AGED; ALPHAPAPILLOMAVIRUS; CARCINOMA, SQUAMOUS CELL; DISEASE-FREE SURVIVAL; FEMALE; HEAD AND NECK NEOPLASMS; HUMAN PAPILLOMAVIRUS 16; HUMAN PAPILLOMAVIRUS 18; HUMANS; MALE; MIDDLE AGED; ONTARIO; OROPHARYNGEAL NEOPLASMS; POLYMERASE CHAIN REACTION; PROGNOSIS; SEROEPIDEMIOLOGIC STUDIES;

EID: 84881262890     PISSN: 19160216     EISSN: None     Source Type: Journal    
DOI: 10.1186/1916-0216-42-9     Document Type: Article

References (20)

1. SEER Cancder Statistics Review, 1975-2008. Bethesda, MD: National Cancer Institute; 2011. http://seer.cancer.gov/csr/1975-2008/.
2. Marur S, D'Souza G, Westra WH, Forastiere AA: HPV-associated head and neck cancer: a virus-related cancer epidemic. Lancet Oncol 2010, 11(8):781-9.
3. Chaturvedi AK, Engels EA, Pfeiffer RM, et al: Human papillomavirus and rising oropharyngeal cancer incidence in the United States. J Clin Oncol 2011, 29(32):4294-301.
4. Nasman A, Attner P, Hammarstedt L, et al: Incidence of human papillomavirus (HPV) positive tonsillar carcinoma in Stockholm, Sweden: an epidemic of viral-induced carcinoma? Int J Cancer 2009, 125(2):362-6.
5. Ang KK, Harris J, Wheeler R, et al: Human papillomavirus and survival of patients with oropharyngeal cancer. N Engl J Med 2010, 363(1):24-35.
6. Nichols AC, Faquin WC, Westra WH, et al: HPV-16 infection predicts treatment outcome in oropharyngeal squamous cell carcinoma. Otolaryngol Head Neck Surg 2009, 140(2):228-34.
7. Kreimer AR, Clifford GM, Boyle P, Franceschi S: Human papillomavirus types in head and neck squamous cell carcinomas worldwide: a systematic review. Cancer Epidemiol Biomarkers Prev 2005, 14(2):467-75.
8. Szkaradkiewicz A, Kruk-Zagajewska A, Wal M, Jopek A, Wierzbicka M, Kuch A: Epstein-Barr virus and human papillomavirus infections and oropharyngeal squamous cell carcinomas. Clin Exp Med 2002, 2(3):137-41.
9. Begum S, Gillison ML, Ansari-Lari MA, Shah K, Westra WH: Detection of human papillomavirus in cervical lymph nodes: a highly effective strategy for localizing site of tumor origin. Clin Cancer Res 2003, 9(17):6469-75.
10. Johnson M, Zaretskaya I, Raytselis Y, Merezhuk Y, McGinnis S, Madden TL: NCBI BLAST: a better web interface. Nucleic Acids Res 2008, 36(Web Server issue):W5-9.
11. Burger RA, Monk BJ, Kurosaki T, et al: Human papillomavirus type 18: association with poor prognosis in early stage cervical cancer. J Natl Cancer Inst 1996, 88(19):1361-8.
12. Huang LW, Chao SL, Hwang JL: Human papillomavirus-31-related types predict better survival in cervical carcinoma. Cancer 2004, 100(2):327-34.
13. Wright JD, Li J, Gerhard DS, et al: Human papillomavirus type and tobacco use as predictors of survival in early stage cervical carcinoma. Gynecol Oncol 2005, 98(1):84-91.
14. Rautava J, Kuuskoski J, Syrjanen K, Grenman R, Syrjanen S: HPV genotypes and their prognostic significance in head and neck squamous cell carcinomas. J Clin Virol 2012, 53(2):116-20.
15. Fakhry C, Westra WH, Li S, et al: Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial. J Natl Cancer Inst 2008, 100(4):261-9.
16. Munoz N, Manalastas R Jr, Pitisuttithum P, et al: Safety, immunogenicity, and efficacy of quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine in women aged 24-45 years: a randomised, double-blind trial. Lancet 2009, 373(9679):1949-57.
17. Palefsky JM, Giuliano AR, Goldstone S, et al: HPV vaccine against anal HPV infection and anal intraepithelial neoplasia. N Engl J Med 2011, 365(17):1576-85.
18. Kliewer EV, Demers AA, Elliott L, Lotocki R, Butler JR, Brisson M: Twenty-year trends in the incidence and prevalence of diagnosed anogenital warts in Canada. Sex Transm Dis 2009, 36(6):380-6.
19. Agrawal N, Frederick MJ, Pickering CR, et al: Exome sequencing of head and neck squamous cell carcinoma reveals inactivating mutations in NOTCH1. Science 2011, 333(6046):1154-7.
20. Stransky N, Egloff AM, Tward AD, et al: The mutational landscape of head and neck squamous cell carcinoma. Science 2011, 333(6046):1157-60.